Compounders just lost their case to put obesity drug tirzepatide back in shortage
A federal court handed the FDA and Eli Lilly a major win in a case challenging the end of the tirzepatide shortage.
On Wednesday, The …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
